CFO
CABA icon

Callan Family Office’s Cabaletta Bio CABA Stock Holding History

Callan Family Office’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.2K Hold
17,434
– – ﹤0.01% 1194
2026
Q1 		$46.9K Sell
17,434
-5,141
-23% -$14.3K ﹤0.01% 1112
2025
Q4 		$49.4K Buy
+22,575
New +$55.9K ﹤0.01% 1090
2025
Q2 		– Sell
-41,599
Closed -$57.6K – 932
2025
Q1 		$57.6K Buy
+41,599
New +$88.6K ﹤0.01% 539

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Callan Family Office's CABA Position: Q2 2026 in Review

Callan Family Office held its Cabaletta Bio (CABA) position steady in Q2 2026 at 17,434 shares worth $54.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

Callan Family Office first reported a position in CABA in Q1 2025 and has held it in 4 quarters since. The position peaked at $57.6K in Q1 2025. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Callan Family Office held 17,434 shares of Cabaletta Bio worth $54.2K as of Q2 2026.
  • Callan Family Office left its Cabaletta Bio share count unchanged in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1194 holding.
  • Callan Family Office first reported a position in Cabaletta Bio in Q1 2025 and has held it in 4 quarters since.
  • Callan Family Office's Cabaletta Bio position peaked at $57.6K in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.